AstraZeneca reportedly bids $10 billion for US biotech Rhythm Pharmaceuticals
Pharmaceutical group AstraZeneca has made a bid worth SEK 97 billion for US-listed Rhythm Pharmaceuticals, sources told the Wall Street Journal (WSJ).
BusinessPharmaceutical group AstraZeneca has made a bid worth SEK 97 billion for US-listed Rhythm Pharmaceuticals, sources told the Wall Street Journal (WSJ).
BusinessYou're up to date in Rhythm Pharmaceuticals
That's every story in Rhythm Pharmaceuticals for now.